Skip to content
10-Q

Quarterly Report

LATAMED AI CORP. LMED

0001477932-26-003348

← back to feed
Filed
May 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 15, 2026 56.13M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$28.38K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$19.02K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $0
Cash And Equivalents Q1 2026 · Dec 31, 2025 $0
Cash And Equivalents Q1 2026 · Mar 31, 2025 $0
Cash And Equivalents Q1 2026 · Dec 31, 2024 $0
Stockholders Equity Q1 2026 · Mar 31, 2026 $7.14M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$630.86K
Stockholders Equity Q1 2026 · Mar 31, 2025 −$598.03K
Stockholders Equity Q1 2026 · Dec 31, 2024 −$573.58K
Current Liabilities Q1 2026 · Mar 31, 2026 $683.67K
Current Liabilities Q1 2026 · Dec 31, 2025 $630.86K
Total Liabilities Q1 2026 · Mar 31, 2026 $683.67K
Total Liabilities Q1 2026 · Dec 31, 2025 $630.86K
Current Assets Q1 2026 · Mar 31, 2026 $0
Current Assets Q1 2026 · Dec 31, 2025 $0
Total Assets Q1 2026 · Mar 31, 2026 $7.82M
Total Assets Q1 2026 · Dec 31, 2025 $0
Sga Expense Q1 2026 · Mar 31, 2026 $9.19K
Sga Expense Q1 2026 · Mar 31, 2025 $967
Net Income Q1 2026 · Mar 31, 2026 −$52.81K
Net Income Q1 2026 · Mar 31, 2025 −$24.46K
Operating Income Q1 2026 · Mar 31, 2026 −$43.38K
Operating Income Q1 2026 · Mar 31, 2025 −$15.97K
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $0